| Particulars |
| Company Name |
Transgene Biotek Ltd |
| Face Value |
10 |
| BSE Code |
526139 |
| Year End |
202603 |
| Full Year |
| Equity (Rs in Cr.) |
75.77 |
| B.V. Rs |
-1.20 |
| Sales Rs in Cr. |
0.21 |
| NP Rs in Cr. |
-1.65 |
| NP Var% |
-144.00 |
| Div% |
0.00 |
| CPS Rs |
-0.20 |
| EPS Rs |
-0.20 |
| Traded Value(Rs in Lakhs) |
0.31 |
| 52 Week High |
4.00 |
| 52 Week Low |
2.00 |
| Price BSE |
2.00 |
| Price NSE |
0.00 |
| Market Capital(Rs in Cr.) |
18.72 |
| P/C Ratio |
-10.40 |
| P/E Ratio |
-9.20 |
| Price Vs.BV |
-1.67 |
| Latest Quarter |
| Year End |
202606 |
| Sales Rs in Cr. |
0.06 |
| NP Rs in Cr. |
-0.39 |
| NP Var % |
10.00 |
| Trailing Twelve Months |
| Year End |
202606 |
| Sales |
0.20 |
| OPM |
-437.13 |
| NP |
-0.27 |
| NP Var% |
-22.84 |
| EPS |
0.00 |
| PE |
0.00 |
|